Based in Edinburgh and positioned to deploy the University’s world-leading expertise in phenotypic screening, stem cell technology and myelin biology, we aim to discover and develop small molecule therapeutics for the treatment of multiple sclerosis.
If you would like to find more, please get in touch using the contact details below.
If you would like to know more about us, please get in touch using the contact details above. Alternatively you can fill in the contact form to send an email directly to info@phenotherapeutics.com.
Pheno Therapeutics
Based in Edinburgh and positioned to deploy the University’s world-leading expertise in phenotypic screening, stem cell technology and myelin biology, we aim to discover and develop small molecule therapeutics that promote remyelination for the treatment of multiple sclerosis.
